JPMorgan Chase & Co. Cuts Dyne Therapeutics (NASDAQ:DYN) Price Target to $17.00
Dyne Therapeutics (NASDAQ:DYN – Free Report) had its price objective decreased by JPMorgan Chase & Co. from $18.00 to $17.00 in a research note released on Friday morning,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the stock. Other analysts have also issued research reports about the stock. HC Wainwright reiterated a […]
Dyne Therapeutics (NASDAQ:DYN – Free Report) had its price objective decreased by JPMorgan Chase & Co. from $18.00 to $17.00 in a research note released on Friday morning,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the stock. Other analysts have also issued research reports about the stock. HC Wainwright reiterated a […]
